Moreover, the specificity of Kv1.3 up-regulation for MS compared to other neurological disorders with or without inflammation, strongly supports the use of Kv1.3 expression as a peripheral biomarker for the disease. The gene discussed is KCNA3; the disease is nervous system disorder.